Table 2: Baseline characteristics of participants in intervention and control groups.

CharacteristicInterventionControl value value

Male17190.420#
Female3836
Age35.5 (16.0)32.9 (13.0)0.9440.347*
BMI23.2 (3.3)22.5 (3.1)1.1620.248*
TG (mmol/L)1.06 (0.58)1.11 (0.96)−0.3370.737*
TC (mmol/L)4.54 (0.99)4.30 (0.82)1.3720.173*
LDL (mmol/L)2.86 (0.86)2.62 (0.72)1.5130.133*
HDL (mmol/L)1.59 (0.40)1.54 (0.35)0.6880.493*
Weight (kg)63.5 (11.2)61.4 (11.8)0.9390.350*
Chest (cm)89.9 (7.7)88.8 (8.0)0.6830.496*
Waist (cm)83.1 (10.1)79.9 (10.6)1.5800.117*
Hip (cm)94.8 (7.4)94.5 (5.7)0.2760.783*
Inferior angle of the scapula (mm)17.7 (5.0)16.2 (4.9)1.6320.106*
Triceps (mm)17.0 (6.2)15.4 (5.0)1.5110.134*
Abdomen (mm)19.2 (5.8)16.4 (5.4)2.5680.012*
Systolic (mmHg)117.3 (12.3)114.4 (13.3)1.0790.284*
Diastolic (mmHg)75.4 (8.8)71.0 (8.7)2.3350.022*
Mean R-R (ms)857.1 (114.4)827.1 (134.4)1.2560.212*
LF%47.2 (22.6)45.8 (20.7)0.3260.745*
HF%172.0 (905.1)54.6 (20.4)0.9610.339*
LF/HF1.5 (1.7)1.4 (2.0)0.1050.917*
VC (L)3,091.6 (1,011.4)3,120.4 (791.4)−0.1630.871*
FVC (L)3.1 (1.0)3.1 (0.8)−0.1450.885*
FEV1 (L)3.0 (1.0)2.8 (0.7)0.6410.523*
FEV1%90.8 (6.8)87.5 (15.6)1.3600.177*
PEF (L/s)5.9 (2.0)6.1 (2.1)−0.3660.715*
PET (s)1.5 (0.5)1.8 (1.1)−1.8190.072*
SR (cm)15.3 (8.7)13.1 (11.2)1.1710.244*
ES (s)39.8 (57.7)29.4 (24.0)1.2110.229*
VO2max (mL/kg·min)28.9 (10.4)27.7 (7.7)0.6880.493*
HRmax (1/min)161.1 (32.9)170.1 (18.7)−1.7440.084*
VEmax (L/min)60.9 (28.9)56.7 (15.5)0.9460.346*
SDS 41.5 (11.1)47.9 (12.0)−2.9000.005*

The chi-square test was used to examine the homogeneity. *The -test was used to examine the homogeneity.